-1651085832.png){kind=logo}
Home
HelpTest Code FUROC UroVysion for Detection of Bladder Cancer, Urine
Useful For
Monitoring for tumor recurrence in patients with a history of urothelial carcinoma involving the bladder or upper urinary tract
Assessing patients with hematuria for urothelial carcinoma
Special Instructions
Method Name
Fluorescence In Situ Hybridization (FISH) using DNA Probes
Reporting Name
UroVysion (R) for Bladder CancerSpecimen Type
VariesNecessary Information
1. Specimen source is required on request form (ie, voided, catheterized, bladder washing).
2. Provide fixative, source, reason for referral (evaluate for urothelial carcinoma or hematuria) and status of diagnosis (known previous diagnosis or suspected/unknown).
Specimen Required
Specimen Type: Urine
Sources: Voided urine, catheterized urine, bladder washings, stoma collections, ureteral brushings or washings, renal pelvic brushings or washings
Supplies: FISH for Urothelial Carcinoma Urine Collection Kit (T509)
Container/Tube:
Preferred: FISH for Urothelial Carcinoma in Urocyte Urine Collection Kit
Acceptable: 70% ethanol, PreservCyt, CytoLyt, ThinPrep UroCyte (UroCyte PreservCyt Solution)
Specimen Volume: 30 mL
Collection Instructions:
1. Follow instructions included with Urocyte Urine Collection Kit.
2. If kit is not used, submit a random urine specimen with an equal volume of 70% ethanol, PreservCyt, or CytoLyt.
Specimen Minimum Volume
See Specimen Required
Specimen Stability Information
| Specimen Type | Temperature | Time | Special Container |
|---|---|---|---|
| Varies | Refrigerated (preferred) | ||
| Ambient | |||
Reject Due To
| Unfixed specimens 48 hours after collection | Reject |
Reference Values
An interpretive report will be provided.
Interpretation
Lower Tract Samples:
Abnormal: any specimen satisfying 1 of the following criteria:
-Four or more cells with gains of 2 or more chromosomes
-Ten or more cells with a gain of a single chromosome or 10 or more cells with tetrasomic signal patterns (ie, 4 copies for each of the 4 probes)
-Homozygous deletion of the 9p21 locus in 20% or more of the cells analyzed
For cases that are abnormal, the percentage of abnormal cells and type of chromosomal abnormality (ie, polysomy, trisomy, tetrasomy, or homozygous 9p21 deletion) are indicated in the test report.
Negative:
-Fewer than 4 cells with gains of 2 or more chromosomes
-Fewer than 10 cells with gain of a single chromosome or tetrasomy
-Less than 20% of cells with homozygous 9p21 deletion
Upper Tract Samples:
Abnormal: any upper tract specimen satisfying 1 of the following criteria:
-Four or more hypertetrasomy cells with at least 5 copies of 2 or more chromosomes
-Ten or more cells with a gain of a single chromosome or 10% or more cells with tetrasomic or near-tetrasomic signal patterns (ie, 4 copies for each of the 4 probes)
-Homozygous deletion of the 9p21 locus in 20% or more of the cells analyzed
Negative:
-Fewer than 4 cells with hypertetrasomy with at least 5 copies of 2 or more chromosomes
-Fewer than 10% of cells with tetrasomy
-Less than 20% of cells with homozygous 9p21 deletion
Day(s) Performed
Monday through Friday
Report Available
7 to 10 daysPerforming Laboratory
Mayo Clinic Laboratories in Rochester
CPT Code Information
88120
LOINC Code Information
| Test ID | Test Order Name | Order LOINC Value |
|---|---|---|
| FUROC | UroVysion (R) for Bladder Cancer | 82251-0 |
| Result ID | Test Result Name | Result LOINC Value |
|---|---|---|
| 54674 | Result Summary | 50397-9 |
| 54675 | Result | 82251-0 |
| 54676 | Interpretation | 69047-9 |
| 54677 | Reason for Referral | 42349-1 |
| 54678 | Specimen | 31208-2 |
| 54679 | Source | 31208-2 |
| 54680 | Released By | 18771-6 |
Forms
1. Pathology/Cytology Information (T707)
2. If not ordering electronically, complete, print, and send an Oncology Test Request (T729) with the specimen.